Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.230
0.00 (0.00%)
At close: Jun 23, 2026, 4:00 PM EDT
1.276
+0.046 (3.74%)
Pre-market: Jun 24, 2026, 4:00 AM EDT
Biomea Fusion Employees
Biomea Fusion had 41 employees as of December 31, 2025. The number of employees decreased by 65 or -61.32% compared to the previous year.
Employees
41
Change
-65
Growth
-61.32%
Revenue / Employee
n/a
Profits / Employee
-$1,096,341
Market Cap
88.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | -65 | -61.32% |
| Sep 30, 2025 | 42 | -65 | -60.75% |
| Jun 30, 2025 | 63 | -49 | -43.75% |
| Mar 31, 2025 | 79 | -31 | -28.18% |
| Dec 31, 2024 | 106 | 3 | 2.91% |
| Sep 30, 2024 | 107 | 4 | 3.88% |
| Jun 30, 2024 | 112 | 18 | 19.15% |
| Mar 31, 2024 | 110 | 24 | 27.91% |
| Dec 31, 2023 | 103 | 20 | 24.10% |
| Sep 30, 2023 | 103 | 28 | 37.33% |
| Jun 30, 2023 | 94 | 22 | 30.56% |
| Mar 31, 2023 | 86 | 29 | 50.88% |
| Dec 31, 2022 | 83 | 32 | 62.75% |
| Sep 30, 2022 | 75 | 28 | 59.57% |
| Jun 30, 2022 | 72 | 52 | 260.00% |
| Mar 31, 2022 | 57 | 37 | 185.00% |
| Dec 31, 2021 | 51 | 39 | 325.00% |
| Sep 30, 2021 | 47 | 35 | 291.67% |
| Jun 30, 2021 | 20 | - | - |
| Mar 31, 2021 | 20 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| ImmuCell | 73 |
| Aardvark Therapeutics | 40 |
| Cardiff Oncology | 31 |
| NeurAxis | 24 |
| iBio, Inc. | 20 |
BMEA News
- 13 days ago - Biomea Fusion Transcript: AGM 2026 - Transcripts
- 18 days ago - Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study - GlobeNewsWire
- 19 days ago - Biomea Fusion management to meet with Citizens - TheFly
- 19 days ago - Biomea Fusion Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 20 days ago - Biomea Fusion partners with University of Leicester on obesity study - TheFly
- 20 days ago - Biomea Fusion Announces Research Collaboration with University of Leicester to Evaluate Icovamenib in Combination with Semaglutide in Obesity - GlobeNewsWire
- 25 days ago - Biomea Fusion Slides: Corporate presentation - Filings
- 5 weeks ago - Biomea Fusion Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts